
▪ | Assets under management end quarter at $1.126 trillion |
▪ | Net revenues of $1.4 billion |
▪ | Diluted earnings per common share of $2.23 |
▪ | Adjusted non-GAAP diluted earnings per common share of $2.13 |
▪ | Long-term investment performance remains strong |
▪ | Net client inflows of $2.5 billion |
Three Months ended | Nine Months ended | ||||||||||||||||||||||
(in millions, except per-share data) | 9/30/2019 | 9/30/2018 | % change | 9/30/2019 | 9/30/2018 | % change | |||||||||||||||||
U.S. GAAP basis | |||||||||||||||||||||||
Investment advisory fees | $ | 1,303.4 | $ | 1,263.3 | 3.2 | % | $ | 3,767.8 | $ | 3,666.9 | 2.8 | % | |||||||||||
Net revenues | $ | 1,426.7 | $ | 1,394.6 | 2.3 | % | $ | 4,149.2 | $ | 4,067.6 | 2.0 | % | |||||||||||
Operating expenses | $ | 767.6 | $ | 754.0 | 1.8 | % | $ | 2,342.5 | $ | 2,248.5 | 4.2 | % | |||||||||||
Net operating income | $ | 659.1 | $ | 640.6 | 2.9 | % | $ | 1,806.7 | $ | 1,819.1 | (.7 | )% | |||||||||||
Non-operating income(1) | $ | 43.0 | $ | 124.9 | n/m | $ | 370.3 | $ | 175.1 | n/m | |||||||||||||
Net income attributable to T. Rowe Price Group | $ | 545.9 | $ | 583.0 | (6.4 | )% | $ | 1,586.0 | $ | 1,485.6 | 6.8 | % | |||||||||||
Diluted earnings per common share | $ | 2.23 | $ | 2.30 | (3.0 | )% | $ | 6.47 | $ | 5.85 | 10.6 | % | |||||||||||
Weighted average common shares outstanding assuming dilution | 238.2 | 247.5 | (3.8 | )% | 239.0 | 248.2 | (3.7 | )% | |||||||||||||||
Adjusted non-GAAP basis(2) | |||||||||||||||||||||||
Operating expenses | $ | 765.1 | $ | 744.5 | 2.8 | % | $ | 2,286.3 | $ | 2,230.8 | 2.5 | % | |||||||||||
Net operating income | $ | 664.2 | $ | 651.6 | 1.9 | % | $ | 1,869.2 | $ | 1,841.4 | 1.5 | % | |||||||||||
Non-operating income(1) | $ | 18.8 | $ | 17.7 | n/m | $ | 98.8 | $ | 25.7 | n/m | |||||||||||||
Net income attributable to T. Rowe Price Group | $ | 521.7 | $ | 505.0 | 3.3 | % | $ | 1,480.4 | $ | 1,423.4 | 4.0 | % | |||||||||||
Diluted earnings per common share | $ | 2.13 | $ | 1.99 | 7.0 | % | $ | 6.04 | $ | 5.60 | 7.9 | % | |||||||||||
Assets under Management (in billions) | |||||||||||||||||||||||
Average assets under management | $ | 1,130.2 | $ | 1,072.4 | 5.4 | % | $ | 1,091.5 | $ | 1,045.0 | 4.4 | % | |||||||||||
Ending assets under management | $ | 1,126.3 | $ | 1,083.8 | 3.9 | % | $ | 1,126.3 | $ | 1,083.8 | 3.9 | % | |||||||||||
▪ | Continued build-out of our investment teams globally. This quarter we created a Tokyo-based multi-asset team to serve local investors’ needs for solutions and diversification, in alignment with our strategic priority to ensure the continued success of our multi-asset business globally. |
▪ | Launch of two new strategies—European Select Equity and Global Government Bond—as part of our SICAV lineup, and the launch of the Target Allocation Active Series Model Portfolios, which are available on Envestnet and Morningstar platforms for financial advisors. |
▪ | Continued success in North American distribution, with early returns from the strategic build-out of our broker-dealer channel in the U.S. and increased traction in Canada with our intermediary clients. |
▪ | Further strengthening and modernization of our operations and technology platforms. This is part of our ongoing long-term plan to make our operating platform more secure, more efficient, and more scalable. |
Three months ended 9/30/2019 | Nine months ended 9/30/2019 | |||||||||||||||||||||||||||||||
(in billions) | U.S. mutual funds | Subadvised and separate accounts | Other investment products | Total | U.S. mutual funds | Subadvised and separate accounts | Other investment products | Total | ||||||||||||||||||||||||
Assets under management at beginning of period | $ | 648.3 | $ | 292.6 | $ | 184.1 | $ | 1,125.0 | $ | 564.5 | $ | 250.0 | $ | 147.8 | $ | 962.3 | ||||||||||||||||
Net cash flows before client transfers | 3.1 | (1.0 | ) | .4 | 2.5 | 7.2 | .4 | 2.8 | 10.4 | |||||||||||||||||||||||
Client transfers | (7.5 | ) | 1.3 | 6.2 | — | (19.5 | ) | .8 | 18.7 | — | ||||||||||||||||||||||
Net cash flows after client transfers | (4.4 | ) | .3 | 6.6 | 2.5 | (12.3 | ) | 1.2 | 21.5 | 10.4 | ||||||||||||||||||||||
Net market appreciation (depreciation) and income | (1.1 | ) | .1 | — | (1.0 | ) | 90.5 | 41.8 | 21.4 | 153.7 | ||||||||||||||||||||||
Net distributions reinvested (not reinvested) | (.2 | ) | — | — | (.2 | ) | (.1 | ) | — | — | (.1 | ) | ||||||||||||||||||||
Change during the period | (5.7 | ) | .4 | 6.6 | 1.3 | 78.1 | 43.0 | 42.9 | 164.0 | |||||||||||||||||||||||
Assets under management at September 30, 2019 | $ | 642.6 | $ | 293.0 | $ | 190.7 | $ | 1,126.3 | $ | 642.6 | $ | 293.0 | $ | 190.7 | $ | 1,126.3 | ||||||||||||||||
Three months ended 9/30/2019 | Nine months ended 9/30/2019 | |||||||||||||||||||||||||||||||
(in billions) | Equity | Fixed income, including money market | Multi-asset(1) | Total | Equity | Fixed income, including money market | Multi-asset(1) | Total | ||||||||||||||||||||||||
Assets under management at beginning of period | $ | 648.4 | $ | 144.1 | $ | 332.5 | $ | 1,125.0 | $ | 539.9 | $ | 136.1 | $ | 286.3 | $ | 962.3 | ||||||||||||||||
Net cash flows | (.6 | ) | 1.3 | 1.8 | 2.5 | (.2 | ) | 3.6 | 7.0 | 10.4 | ||||||||||||||||||||||
Net market appreciation (depreciation) and income(2) | (4.3 | ) | 1.2 | 1.9 | (1.2 | ) | 103.8 | 6.9 | 42.9 | 153.6 | ||||||||||||||||||||||
Change during the period | (4.9 | ) | 2.5 | 3.7 | 1.3 | 103.6 | 10.5 | 49.9 | 164.0 | |||||||||||||||||||||||
Assets under management at September 30, 2019 | $ | 643.5 | $ | 146.6 | $ | 336.2 | $ | 1,126.3 | $ | 643.5 | $ | 146.6 | $ | 336.2 | $ | 1,126.3 | ||||||||||||||||
▪ | Investment advisory revenues earned in Q3 2019 from the firm's U.S. mutual funds were $881.0 million, an increase of 0.4% from Q3 2018. Average assets under management in these funds increased 1.4% to $650.5 billion in Q3 2019. |
▪ | Investment advisory revenues earned in Q3 2019 from subadvised, separate accounts, and other investment products were $422.4 million, an increase of 9.4% from Q3 2018. Average assets under management for these products increased 11.3% to $479.7 billion in Q3 2019. |
▪ | The effective fee rate of 45.8 basis points in Q3 2019 decreased from 46.3 basis points in Q2 2019 and was lower than the 46.7 basis points in Q3 2018. The decline in the effective fee rate from Q2 2019 is largely due to a market-driven shift of assets under management from higher fee international equity strategies to lower fee strategies. Client transfers to lower fee vehicles or share classes over the last twelve months and, to a lesser extent, fee reductions the firm has made since Q3 2018 also drove the effective fee rate lower compared to Q3 2018. Over time, the firm's effective fee rate can be impacted by market or cash flow related shifts among asset and share classes, price changes in existing products, and asset level changes in products with tiered-fee structures. |
▪ | Administrative, distribution, and servicing fees in Q3 2019 were $123.3 million, a decrease of $8.0 million from Q3 2018. The decrease was primarily attributable to lower 12b-1 revenue earned on certain share classes of the U.S. mutual funds. The 12b-1 revenue decline is offset entirely by a reduction in the costs paid to third-party intermediaries that source these assets and is reported in distribution and servicing expense. |
▪ | On a non-GAAP basis, the firm's operating expenses in Q3 2019 increased 2.8% to $765.1 million compared with Q3 2018, while non-GAAP operating expense growth for the nine months ended |
▪ | Compensation and related costs were $466.3 million in Q3 2019, an increase of 2.6%. This increase was primarily related to a 3.3% growth in average headcount, the annual bonus accrual, and other employee-related expenses. The firm employed 7,262 associates at September 30, 2019. These increases in compensation expense were partially offset by lower market-driven compensation expenses related to the supplemental savings plan in Q3 2019 as compared to Q3 2018. |
▪ | Distribution and servicing includes those costs incurred to distribute T. Rowe Price products and to provide client or shareholder servicing, recordkeeping, and administrative services. These costs were |
▪ | Technology, occupancy, and facility costs were $106.5 million in Q3 2019, an increase of 10.4% from the $96.5 million recognized in Q3 2018. The increase was due to incremental investment in the firm's technology capabilities, including related depreciation, hosted solution licenses, and maintenance programs, as well as increased office facility costs. |
Three months ended | Nine months ended | |||||||||||
9/30/2019 | 9/30/2018 | 9/30/2019 | 9/30/2018 | |||||||||
Statutory U.S. federal income tax rate | 21.0 | % | 21.0 | % | 21.0 | % | 21.0 | % | ||||
Impact of nonrecurring charge related to U.S. tax reform recognized in the second quarter | — | — | — | 1.0 | ||||||||
Impact of nonrecurring charge related to new Maryland state tax legislation recognized in the second quarter | — | — | — | .4 | ||||||||
State income taxes for current year, net of federal income tax benefits(1) | 4.4 | 4.8 | 4.4 | 4.6 | ||||||||
Net income attributable to redeemable non-controlling interests | (.8 | ) | (.1 | ) | (.8 | ) | (.2 | ) | ||||
Net excess tax benefits from stock-based compensation plans activity | (1.2 | ) | (.8 | ) | (.9 | ) | (1.8 | ) | ||||
Other items | (1.0 | ) | (.9 | ) | .3 | (.1 | ) | |||||
Effective income tax rate | 22.4 | % | 24.0 | % | 24.0 | % | 24.9 | % | ||||
(in millions) | 9/30/2019 | 12/31/2018 | ||||||
Cash and cash equivalents | $ | 2,213.2 | $ | 1,425.2 | ||||
Discretionary investments | 1,695.1 | 1,597.1 | ||||||
Total cash and discretionary investments | 3,908.3 | 3,022.3 | ||||||
Redeemable seed capital investments | 1,257.7 | 1,118.9 | ||||||
Investments used to hedge the supplemental savings plan liability | 443.0 | 381.3 | ||||||
Total cash and investments in T. Rowe Price products | $ | 5,609.0 | $ | 4,522.5 | ||||
▪ | The firm's common shares outstanding were 234.7 million at September 30, 2019, compared with 238.1 million at the end of 2018. |
▪ | In the first nine months of 2019, the firm expended $566.7 million to repurchase 5.7 million shares, or 2.4%, of its outstanding common shares at an average price of $99.57, including $173.1 million to repurchase 1.6 million shares during Q3 2019. |
▪ | The firm invested $148.9 million during the first nine months of 2019 in capitalized facilities and technology and expects capital expenditures for 2019 to be up to $200 million, of which about two-thirds is planned for technology initiatives. These expenditures are expected to continue to be funded from the firm's operating resources. |
1 year | 3 years | 5 years | 10 years | |||||
Outperformed Morningstar median | ||||||||
All funds | 73% | 68% | 75% | 81% | ||||
Multi-asset funds | 86% | 74% | 85% | 84% | ||||
Top Morningstar quartile | ||||||||
All funds | 43% | 45% | 52% | 57% | ||||
Multi-asset funds | 47% | 56% | 62% | 79% | ||||
Public Relations | Investor Relations | ||
Brian Lewbart | Meghan Azevedo | ||
410-345-2242 | 410-345-2756 | ||
brian_lewbart@troweprice.com | meghan_azevedo@troweprice.com | ||
Unaudited Consolidated Statements of Income | |||||||||||||||||
(in millions, except per-share amounts) | |||||||||||||||||
Three months ended | Nine months ended | ||||||||||||||||
Revenues | 9/30/2019 | 9/30/2018 | 9/30/2019 | 9/30/2018 | |||||||||||||
Investment advisory fees | $ | 1,303.4 | $ | 1,263.3 | $ | 3,767.8 | $ | 3,666.9 | |||||||||
Administrative, distribution, and servicing fees | 123.3 | 131.3 | 381.4 | 400.7 | |||||||||||||
Net revenues | 1,426.7 | 1,394.6 | 4,149.2 | 4,067.6 | |||||||||||||
Operating expenses | |||||||||||||||||
Compensation and related costs | 466.3 | 454.3 | 1,441.0 | 1,351.7 | |||||||||||||
Distribution and servicing | 64.5 | 71.4 | 195.3 | 213.3 | |||||||||||||
Advertising and promotion | 17.1 | 20.2 | 58.5 | 63.8 | |||||||||||||
Product-related costs | 38.0 | 37.9 | 115.6 | 117.1 | |||||||||||||
Technology, occupancy, and facility costs | 106.5 | 96.5 | 309.5 | 283.8 | |||||||||||||
General, administrative, and other | 75.2 | 73.7 | 222.6 | 218.8 | |||||||||||||
Total operating expenses | 767.6 | 754.0 | 2,342.5 | 2,248.5 | |||||||||||||
Net operating income | 659.1 | 640.6 | 1,806.7 | 1,819.1 | |||||||||||||
Non-operating income | |||||||||||||||||
Net gains on investments | 32.1 | 116.1 | 194.0 | 147.9 | |||||||||||||
Net gains on consolidated investment products | 11.6 | 8.7 | 176.3 | 28.6 | |||||||||||||
Other income (loss) | (.7 | ) | .1 | — | (1.4 | ) | |||||||||||
Total non-operating income | 43.0 | 124.9 | 370.3 | 175.1 | |||||||||||||
Income before income taxes | 702.1 | 765.5 | 2,177.0 | 1,994.2 | |||||||||||||
Provision for income taxes | 157.0 | 183.9 | 522.0 | 497.5 | |||||||||||||
Net income | 545.1 | 581.6 | 1,655.0 | 1,496.7 | |||||||||||||
Less: net income (loss) attributable to redeemable non-controlling interests | (.8 | ) | (1.4 | ) | 69.0 | 11.1 | |||||||||||
Net income attributable to T. Rowe Price Group | 545.9 | 583.0 | 1,586.0 | 1,485.6 | |||||||||||||
Less: net income allocated to outstanding restricted stock and stock unit holders | 13.9 | 13.7 | 40.7 | 34.8 | |||||||||||||
Net income allocated to T. Rowe Price Group common stockholders | $ | 532.0 | $ | 569.3 | $ | 1,545.3 | $ | 1,450.8 | |||||||||
Earnings per share | |||||||||||||||||
Basic | $ | 2.26 | $ | 2.34 | $ | 6.55 | $ | 5.97 | |||||||||
Diluted | $ | 2.23 | $ | 2.30 | $ | 6.47 | $ | 5.85 | |||||||||
Weighted-average common shares | |||||||||||||||||
Outstanding | 234.9 | 242.8 | 235.8 | 243.1 | |||||||||||||
Outstanding assuming dilution | 238.2 | 247.5 | 239.0 | 248.2 | |||||||||||||
Investment Advisory Revenues (in millions) | Three months ended | Nine months ended | ||||||||||||||
9/30/2019 | 9/30/2018 | 9/30/2019 | 9/30/2018 | |||||||||||||
U.S. mutual funds | ||||||||||||||||
Equity and blended assets | $ | 754.0 | $ | 745.5 | $ | 2,185.3 | $ | 2,169.0 | ||||||||
Fixed income, including money market | 127.0 | 131.8 | 372.3 | 388.1 | ||||||||||||
881.0 | 877.3 | 2,557.6 | 2,557.1 | |||||||||||||
Subadvised and separate accounts and other investment products | ||||||||||||||||
Equity and blended assets | 355.9 | 326.0 | 1,020.8 | 931.0 | ||||||||||||
Fixed income, including money market | 66.5 | 60.0 | 189.4 | 178.8 | ||||||||||||
422.4 | 386.0 | 1,210.2 | 1,109.8 | |||||||||||||
Total | $ | 1,303.4 | $ | 1,263.3 | $ | 3,767.8 | $ | 3,666.9 | ||||||||
Assets Under Management (in billions) | Average during | ||||||||||||||||||||||||
Three months ended | Nine months ended | As of | |||||||||||||||||||||||
9/30/2019 | 9/30/2018 | 9/30/2019 | 9/30/2018 | 9/30/2019 | 12/31/2018 | ||||||||||||||||||||
U.S. mutual funds | |||||||||||||||||||||||||
Equity and blended assets | $ | 521.3 | $ | 511.6 | $ | 507.5 | $ | 500.8 | $ | 513.0 | $ | 441.1 | |||||||||||||
Fixed income, including money market | 129.2 | 129.9 | 125.7 | 128.6 | 129.6 | 123.4 | |||||||||||||||||||
650.5 | 641.5 | 633.2 | 629.4 | 642.6 | 564.5 | ||||||||||||||||||||
Subadvised and separate accounts and other investment products | |||||||||||||||||||||||||
Equity and blended assets | 370.2 | 331.8 | 353.3 | 318.4 | 373.4 | 299.2 | |||||||||||||||||||
Fixed income, including money market | 109.5 | 99.1 | 105.0 | 97.2 | 110.3 | 98.6 | |||||||||||||||||||
479.7 | 430.9 | 458.3 | 415.6 | 483.7 | 397.8 | ||||||||||||||||||||
Total | $ | 1,130.2 | $ | 1,072.4 | $ | 1,091.5 | $ | 1,045.0 | $ | 1,126.3 | $ | 962.3 | |||||||||||||
Net Cash Flows After Client Transfers (by investment vehicle and underlying asset class)(1)(2) | Three months ended | Nine months ended | ||||||
(in billions) | 9/30/2019 | 9/30/2019 | ||||||
U.S. mutual funds | ||||||||
Equity and blended assets | $ | (5.6 | ) | $ | (10.7 | ) | ||
Fixed income, including money market | 1.2 | (1.6 | ) | |||||
(4.4 | ) | (12.3 | ) | |||||
Subadvised and separate accounts and other investment products | ||||||||
Equity and blended assets | 5.8 | 16.7 | ||||||
Fixed income, including money market | 1.1 | 6.0 | ||||||
6.9 | 22.7 | |||||||
Total net cash flows after client transfers | $ | 2.5 | $ | 10.4 | ||||
Non-Operating Income (in millions) | Three months ended | Nine months ended | ||||||||||||||
9/30/2019 | 9/30/2018 | 9/30/2019 | 9/30/2018 | |||||||||||||
Net gains (losses) from non-consolidated T. Rowe Price investment products | ||||||||||||||||
Cash and discretionary investments | ||||||||||||||||
Dividend income | $ | 18.1 | $ | 13.8 | $ | 52.2 | $ | 31.0 | ||||||||
Market related gains (losses) and equity in earnings | .7 | 3.9 | 46.6 | (1.0 | ) | |||||||||||
Seed capital investments | ||||||||||||||||
Dividend income | .2 | .6 | 1.0 | 2.7 | ||||||||||||
Market related gains (losses) and equity in earnings | 2.6 | 3.2 | 30.9 | (5.5 | ) | |||||||||||
Net gain (loss) recognized upon deconsolidation | (.1 | ) | — | .1 | 3.6 | |||||||||||
Investments used to hedge the supplemental savings plan liability | 1.7 | 6.3 | 44.8 | 14.2 | ||||||||||||
Total net gains from non-consolidated T. Rowe Price investment products | 23.2 | 27.8 | 175.6 | 45.0 | ||||||||||||
Other investment income | 8.9 | 88.3 | 18.4 | 102.9 | ||||||||||||
Net gains on investments | 32.1 | 116.1 | 194.0 | 147.9 | ||||||||||||
Net gains on consolidated sponsored investment portfolios | 11.6 | 8.7 | 176.3 | 28.6 | ||||||||||||
Other income (loss), including foreign currency gains and losses | (.7 | ) | .1 | — | (1.4 | ) | ||||||||||
Non-operating income | $ | 43.0 | $ | 124.9 | $ | 370.3 | $ | 175.1 | ||||||||
Unaudited Condensed Consolidated Cash Flows Information (in millions) | ||||||||||||||||||||||||
Nine months ended | ||||||||||||||||||||||||
9/30/2019 | 9/30/2018 | |||||||||||||||||||||||
Cash flow attributable to T. Rowe Price Group | Cash flow attributable to consolidated T. Rowe Price investment products, net of eliminations | As reported on statement of cash flows | Cash flow attributable to T. Rowe Price Group | Cash flow attributable to consolidated T. Rowe Price investment products, net of eliminations | As reported on statement of cash flows | |||||||||||||||||||
Cash provided by (used in) operating activities, including $136.1 of stock-based compensation expense and $131.7 of depreciation expense in 2019 | $ | 2,028.1 | $ | (527.4 | ) | $ | 1,500.7 | $ | 2,060.9 | $ | (574.5 | ) | $ | 1,486.4 | ||||||||||
Cash provided by (used in) investing activities, including ($148.9) for additions to property and equipment and ($35.0) of additions to T. Rowe Price investment products in 2019 | (230.0 | ) | 153.3 | (76.7 | ) | (923.7 | ) | 93.3 | (830.4 | ) | ||||||||||||||
Cash provided by (used in) financing activities, including T. Rowe Price Group common stock repurchases of ($576.0)* and dividends paid of ($550.4) in 2019 | (1,010.1 | ) | 387.1 | (623.0 | ) | (949.3 | ) | 486.2 | (463.1 | ) | ||||||||||||||
Effect of exchange rate changes on cash and cash equivalents | — | (2.2 | ) | (2.2 | ) | — | (2.4 | ) | (2.4 | ) | ||||||||||||||
Net change in cash and cash equivalents during period | $ | 788.0 | $ | 10.8 | $ | 798.8 | $ | 187.9 | $ | 2.6 | $ | 190.5 | ||||||||||||
Unaudited Condensed Consolidated Balance Sheet Information (in millions) | As of | |||||||
9/30/2019 | 12/31/2018 | |||||||
Cash and cash equivalents | $ | 2,213.2 | $ | 1,425.2 | ||||
Accounts receivable and accrued revenue | 620.6 | 549.6 | ||||||
Investments | 2,605.9 | 2,453.4 | ||||||
Assets of consolidated T. Rowe Price investment products | 2,247.4 | 1,680.4 | ||||||
Property and equipment, net | 678.8 | 661.3 | ||||||
Goodwill | 665.7 | 665.7 | ||||||
Other assets, including operating lease assets in 2019 | 366.2 | 253.7 | ||||||
Total assets | 9,397.8 | 7,689.3 | ||||||
Total liabilities, includes $80.4 at September 30, 2019, and $38.7 at December 31, 2018, from consolidated T. Rowe Price investment products | 1,455.1 | 824.7 | ||||||
Redeemable non-controlling interests | 1,102.9 | 740.3 | ||||||
Stockholders' equity, 234.7 common shares outstanding at September 30, 2019 | $ | 6,839.8 | $ | 6,124.3 | ||||
Cash, Cash Equivalents, and Investments Information (in millions) | ||||||||||||||||
Cash and cash equivalents | Investments | Net assets of consolidated T. Rowe Price investment products | 9/30/2019 | |||||||||||||
Cash and discretionary investments | $ | 2,213.2 | $ | 1,626.2 | $ | 68.9 | $ | 3,908.3 | ||||||||
Seed capital investments | — | 262.5 | 995.2 | 1,257.7 | ||||||||||||
Investments used to hedge the supplemental savings plan liability | — | 443.0 | — | 443.0 | ||||||||||||
Total cash and investments in T. Rowe Price products attributable to T. Rowe Price Group | 2,213.2 | 2,331.7 | 1,064.1 | 5,609.0 | ||||||||||||
Investment in UTI and other investments | — | 274.2 | — | 274.2 | ||||||||||||
Total cash and investments attributable to T. Rowe Price Group | 2,213.2 | 2,605.9 | 1,064.1 | 5,883.2 | ||||||||||||
Redeemable non-controlling interests | — | — | 1,102.9 | 1,102.9 | ||||||||||||
As reported on unaudited condensed consolidated balance sheet at September 30, 2019 | $ | 2,213.2 | $ | 2,605.9 | $ | 2,167.0 | $ | 6,986.1 | ||||||||
Three months ended 9/30/2019 | |||||||||||||||||||||||
Operating expenses | Net operating income | Non-operating income | Provision (benefit) for income taxes(6) | Net income attributable to T. Rowe Price Group | Diluted earnings per share(7) | ||||||||||||||||||
U.S. GAAP Basis | $ | 767.6 | $ | 659.1 | $ | 43.0 | $ | 157.0 | $ | 545.9 | $ | 2.23 | |||||||||||
Non-GAAP adjustments: | |||||||||||||||||||||||
Consolidated T. Rowe Price investment products(1) | (1.1 | ) | 3.7 | (11.6 | ) | 4.6 | (13.3 | ) | (.05 | ) | |||||||||||||
Supplemental savings plan liability(2) | (1.4 | ) | 1.4 | (1.7 | ) | (.6 | ) | .3 | — | ||||||||||||||
Other non-operating income(3) | — | — | (10.9 | ) | .3 | (11.2 | ) | (.05 | ) | ||||||||||||||
Adjusted Non-GAAP Basis | $ | 765.1 | $ | 664.2 | $ | 18.8 | $ | 161.3 | $ | 521.7 | $ | 2.13 | |||||||||||
Three months ended 9/30/2018 | |||||||||||||||||||||||
Operating expenses | Net operating income | Non-operating income | Provision (benefit) for income taxes(6) | Net income attributable to T. Rowe Price Group | Diluted earnings per share(7) | ||||||||||||||||||
U.S. GAAP Basis | $ | 754.0 | $ | 640.6 | $ | 124.9 | $ | 183.9 | $ | 583.0 | $ | 2.30 | |||||||||||
Non-GAAP adjustments: | |||||||||||||||||||||||
Consolidated T. Rowe Price investment products(1) | (2.1 | ) | 3.6 | (8.7 | ) | (1.2 | ) | (5.3 | ) | (.02 | ) | ||||||||||||
Supplemental savings plan liability(2) | (7.4 | ) | 7.4 | (6.3 | ) | .4 | .7 | — | |||||||||||||||
Other non-operating income(3) | — | — | (92.2 | ) | (18.8 | ) | (73.4 | ) | (.29 | ) | |||||||||||||
Adjusted Non-GAAP Basis | $ | 744.5 | $ | 651.6 | $ | 17.7 | $ | 164.3 | $ | 505.0 | $ | 1.99 | |||||||||||
Nine months ended 9/30/2019 | |||||||||||||||||||||||
Operating expenses | Net operating income | Non-operating income | Provision (benefit) for income taxes(6) | Net income attributable to T. Rowe Price Group | Diluted earnings per share(7) | ||||||||||||||||||
U.S. GAAP Basis | $ | 2,342.5 | $ | 1,806.7 | $ | 370.3 | $ | 522.0 | $ | 1,586.0 | $ | 6.47 | |||||||||||
Non-GAAP adjustments: | |||||||||||||||||||||||
Consolidated T. Rowe Price investment products(1) | (4.3 | ) | 10.6 | (176.3 | ) | (23.7 | ) | (73.0 | ) | (.30 | ) | ||||||||||||
Supplemental savings plan liability(2) | (51.9 | ) | 51.9 | (44.8 | ) | 1.7 | 5.4 | .03 | |||||||||||||||
Other non-operating income(3) | — | — | (50.4 | ) | (12.4 | ) | (38.0 | ) | (.16 | ) | |||||||||||||
Adjusted Non-GAAP Basis | $ | 2,286.3 | $ | 1,869.2 | $ | 98.8 | $ | 487.6 | $ | 1,480.4 | $ | 6.04 | |||||||||||
Nine months ended 9/30/2018 | |||||||||||||||||||||||
Operating expenses | Net operating income | Non-operating income | Provision (benefit) for income taxes(6) | Net income attributable to T. Rowe Price Group | Diluted earnings per share(7) | ||||||||||||||||||
U.S. GAAP Basis | $ | 2,248.5 | $ | 1,819.1 | $ | 175.1 | $ | 497.5 | $ | 1,485.6 | $ | 5.85 | |||||||||||
Non-GAAP adjustments: | |||||||||||||||||||||||
Consolidated T. Rowe Price investment products(1) | (4.6 | ) | 9.2 | (28.6 | ) | (1.8 | ) | (6.5 | ) | (.03 | ) | ||||||||||||
Supplemental savings plan liability(2) | (13.1 | ) | 13.1 | (14.2 | ) | (.2 | ) | (.9 | ) | — | |||||||||||||
Other non-operating income(3) | — | — | (106.6 | ) | (23.1 | ) | (83.5 | ) | (.33 | ) | |||||||||||||
Nonrecurring charge related to enactment of U.S. tax reform(4) | — | — | — | (20.8 | ) | 20.8 | .08 | ||||||||||||||||
Nonrecurring charge related to enactment of Maryland state tax legislation(5) | — | — | — | (7.9 | ) | 7.9 | .03 | ||||||||||||||||
Adjusted Non-GAAP Basis | $ | 2,230.8 | $ | 1,841.4 | $ | 25.7 | $ | 443.7 | $ | 1,423.4 | $ | 5.60 | |||||||||||
(1) | These non-GAAP adjustments remove the impact the consolidated T. Rowe Price investment products have on the firm's U.S. GAAP consolidated statements of income. Specifically, the firm adds back the operating expenses and subtracts the investment income of the consolidated T. Rowe Price investment products. The adjustment to operating expenses represents the operating expenses of the consolidated products, net of the elimination of related management and administrative fees. The adjustment to net income attributable to T. Rowe Price Group represents the net income of the consolidated products, net of redeemable non-controlling interest. Management believes the consolidated T. Rowe Price investment products may impact the reader’s ability to understand the firm's core operating results. |
(2) | This non-GAAP adjustment removes the compensation expense from market valuation changes in the supplemental savings plan liability and the related net gains (losses) on investments designated as an economic hedge against the related liability. Amounts deferred under the supplemental savings plan are adjusted for appreciation (depreciation) of hypothetical investments chosen by participants. The firm uses T. Rowe Price investment products to economically hedge the exposure to these market movements. Management believes it is useful to offset the non-operating investment income (loss) realized on the hedges against the related compensation expense and remove the net impact to help the reader's ability to understand the firm's core operating results and to increase comparability period to period. |
(3) | This non-GAAP adjustment represents the other non-operating income (loss) and the net gains (losses) earned on the firm's non-consolidated investment portfolio that are not designated as economic hedges of the supplemental savings plan liability, and, beginning in the second quarter of 2018, those non-consolidated investments that are not part of the cash and discretionary investment portfolio. Management decided to retain the investment gains recognized on the non-consolidated cash and discretionary investments as these assets and related income (loss) are considered part of the firm's core operations. The impact on previously reported non-GAAP measures is immaterial. Management believes adjusting for these non-operating income (loss) items helps the reader’s ability to understand the firm's core operating results and increases |
(4) | During the second quarter of 2018, the firm recognized a nonrecurring charge of $20.8 million for an adjustment made to the charge taken in 2017 related to the enactment of U.S. tax reform. Management believes it is useful to readers of its consolidated statements of income to adjust for this nonrecurring charge in arriving at net income attributable to T. Rowe Price Group and diluted earnings per share. |
(5) | During the second quarter of 2018, the firm recognized a nonrecurring charge of $7.9 million for the remeasurement of its deferred tax assets and liabilities to reflect the effect of Maryland state tax legislation enacted on April 24, 2018. Management believes it is useful to readers of its consolidated statements of income to adjust for this nonrecurring charge in arriving at net income attributable to T. Rowe Price Group and diluted earnings per share. |
(6) | The income tax impacts were calculated in order to achieve an overall year-to-date non-GAAP effective tax rate of 24.8% in 2019 and 23.8% in 2018. As such, the non-GAAP effective tax rate for the third quarter was 23.6% in 2019 and 24.5% in 2018. The firm estimates that its effective tax rate for the full-year 2019 on a non-GAAP basis will be in the range of 23.5% to 25.5%. |
(7) | This non-GAAP measure was calculated by applying the two-class method to adjusted net income attributable to T. Rowe Price Group divided by the weighted-average common shares outstanding assuming dilution. |